Neil Gallagher - Apr 10, 2023 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
3
Date filed
4/12/2023, 04:01 PM
Next filing
Feb 9, 2024

No securities are beneficially owned.